Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» vaccines
vaccines
Is Novavax, the latecomer COVID vaccine, worth the wait?
Medical Marketing and Media
Mon, 11/20/23 - 10:20 am
Novavax
vaccines
COVID-19
Japan to buy 1.4 mln doses of Daiichi Sankyo COVID vaccine
Reuters
Thu, 11/16/23 - 10:22 pm
Japan
Daiichi Sankyo
COVID-19
vaccines
Valneva single-dose chikungunya vaccine poised to ‘revolutionize’ global health
Biopharma Reporter
Thu, 11/16/23 - 11:38 am
Valneva
vaccines
Ixchiq
FDA
chikungunya virus
IO Biotech concludes subject enrollment in melanoma vaccine trial
Clinical Trials Arena
Mon, 11/13/23 - 09:57 am
IO Biotech
clinical trial
melanoma
vaccines
FDA approves Valneva's chikungunya vaccine
Reuters
Thu, 11/9/23 - 11:39 pm
Valneva
vaccines
chikungunya virus
FDA
Ixchiq
Novavax posts higher-than-expected revenue, says prepared to further cut costs
Reuters
Thu, 11/9/23 - 09:45 am
Novavax
earnings
vaccines
COVID-19
Moderna's Stock Just Tumbled 12%. Here's Why It's Still a Buy.
Motley Fool
Thu, 11/9/23 - 09:40 am
Moderna Therapeutics
vaccines
COVID-19
RSV is on the rise but preventative drugs are in short supply
MIT Technology Review
Mon, 11/6/23 - 10:04 am
RSV
CDC
vaccines
nirsevimab
drug shortages
AstraZeneca
Moderna takes hefty $1.3B COVID write-off, scales back manufacturing as sales shrink
Fierce Pharma
Thu, 11/2/23 - 11:43 am
Moderna Therapeutics
earnings
vaccines
COVID-19
GSK outpaces Pfizer in RSV vaccine market
BioPharma Dive
Wed, 11/1/23 - 11:19 am
GSK
Pfizer
vaccines
RSV
Arexvy
Abrysvo
Pfizer RSV vaccine gets off to fast start on market
BioPharma Dive
Tue, 10/31/23 - 09:21 pm
Pfizer
RSV
vaccines
Abrysvo
A continuing decline in sales of COVID-19 products clips revenue at Pfizer
Yahoo Finance
Tue, 10/31/23 - 10:21 am
Pfizer
earnings
COVID-19
vaccines
Paxlovid
Pfizer's mRNA flu vaccine hits primary goals in phase 3 trial, but secondary miss raises questions
Fierce Biotech
Tue, 10/31/23 - 10:15 am
Pfizer
vaccines
clinical trials
MRNA
Flu
Moderna joins CEPI's 100 Days Mission to advance pandemic preparedness
Fierce Biotech
Mon, 10/30/23 - 10:19 am
Moderna Therapeutics
MRNA
CEPI
vaccines
pandemic
Pfizer, BioNTech prep flu-COVID mRNA combo shot for phase 3, reprising Moderna race after seeing early data
Fierce Biotech
Thu, 10/26/23 - 11:55 am
Pfizer
BioNTech
Moderna Therapeutics
vaccines
MRNA
flu-COVID combo vaccines
Araclon vaccine appears to slow Alzheimer's in exploratory phase 2 analysis, spurring review of next steps
Fierce Biotech
Wed, 10/25/23 - 09:56 am
Araclon
Grifols
Alzheimer's disease
clinical trials
vaccines
ABvac40
GSK targets younger age group with RSV vaccine Arexvy
Pharmaphorum
Wed, 10/25/23 - 09:43 am
GSK
RSV
Arexvy
vaccines
Pfizer’s new shot approval adds to a growing vaccine prowess
Pharma Voice
Tue, 10/24/23 - 10:23 am
Pfizer
vaccines
meningococcal disease
COVID-19
Penbraya
AZ seeks FDA okay for first self-administered flu vaccine
Pharmaphorum
Tue, 10/24/23 - 10:03 am
AstraZeneca
FDA
FluMist Quadrivalent
vaccines
flu vaccines
self-administered vaccines
Maternal Covid-19 vaccination offers infants immunity for up to 6 months
Stat
Mon, 10/23/23 - 05:03 pm
COVID-19
vaccines
Pfizer
BioNTech
pregnancy
pediatric
maternal vaccines
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »